ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1340 National Cancer Institute Html en Cigar Smoking and Cancer A fact sheet about the health risks associated with cigar smoking.
U.S. cigarettes0.435012
safe level0.447421
daily cigar smokers0.575561
lung disease0.3915
U.S. Department0.408687
Tobacco Control Research0.449796
cigarette wrappers0.39436
fact sheet0.390339
smoking cigarettes0.411876
cigar smoke0.9529
smaller cigar0.493729
higher level0.393813
tobacco wrapper0.424842
tobacco0.68829
little cigars0.531809
cancer-causing chemicals0.523406
single cigar0.473523
tobacco equivalent0.423502
tobacco smoke0.637174
nicotine replacement therapy0.395273
premium cigars0.430441
cigar tobacco0.599849
Yes. Cigar smoke0.635443
Cigar smoking causes0.545544
tobacco products0.458198
nonporous cigar wrapper0.527496
longer smoking time0.409949
cigar sizes0.492999
Step-by-Step Quit Guide0.399635
nicotine replacement products0.450092
cigar smokers0.686977
cigarettes0.521293
help quitting smoking0.41788
NCI fact sheet0.38899
cigar smoking0.555875
Cigar wrappers0.48618
cigarette smoke0.705986
heart disease0.392368
large cigars0.512534
esophageal cancer risks0.38664
cigarette tobacco0.465692
cigars0.636157
cigarette smokers0.616772
cigar smoking.  Journal0.511307
oral cavity cancers0.409515
Services.  Reducing Tobacco0.446373
Regular cigar smokers0.574584
oral cavity0.439868
safe tobacco product0.484172
CLICK HERE
1395 National Cancer Institute Html en Neuroblastoma Screening (PDQ®)–Health Professional Version Expert-reviewed information summary about tests used to detect or screen for neuroblastoma.
mass screening0.633479
screening cohort0.50328
final mortality rates0.477635
neuroblastoma incidence0.659367
standard cutoff levels0.372395
unamplified N-myc oncogene0.370313
Cumulative incidence0.42237
neuroblastoma mortality0.605343
standard deviations0.367415
Great Britain0.357629
positive-predictive value0.368634
high survival rate0.357977
performance liquid chromatography0.367159
children0.418147
mortality).0.40606
mortality trends0.41083
neuroblastoma death rate0.464758
biologically favorable prognoses0.367208
urinary screening0.478583
standardized mortality ratio0.459583
HVA cut-off level0.405483
standard incidence ratio0.405002
screening procedure0.51747
once-in-a-lifetime screening test0.638106
liquid urine samples0.367329
VMA cut-off level0.376999
mass screening program0.578067
early-stage disease0.366779
uncontrolled pilot experiences0.369023
birth cohorts0.378521
German Neuroblastoma Screening0.729232
gas chromatography0.385439
Japanese experience0.358474
serial noninvasive testing0.364665
American birth cohorts0.372668
cumulative mortality rates0.516107
favorable neuroblastoma0.427972
neonatal screening0.550878
neuroblastoma excrete0.450446
German neuroblastoma study.0.461849
Quebec Neuroblastoma Screening0.841856
age-specific mortality rates0.512048
cases0.401583
improved survival rates0.372705
μg/mg creatinine0.367455
overall mortality0.41267
5-year birth cohort0.366222
Neuroblastoma Screening Project0.944535
standardized incidence ratio0.40319
CLICK HERE
1409 National Cancer Institute Html en Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Prevention (PDQ®)–Patient Version Expert-reviewed information summary about factors that may influence the risk of developing ovarian, fallopian tube, and primary peritoneal cancers and about research aimed at the prevention of them.
cancer risk factors0.421609
oral contraceptives0.394634
cancer treatment0.361951
Cancer prevention0.515594
cancer prevention trials0.422093
invasive ovarian cancer0.476074
primary peritoneal cancers0.449406
nonpolyposis colorectal cancer0.387747
cancer protective factor0.395471
decreased risk0.397035
prevention clinical trials0.392562
protective factors0.425839
gene changes0.362438
clinical trials0.530283
Cancer Information Service0.386071
following PDQ summaries0.382587
PDQ cancer information0.483395
ovarian cancer cells0.47684
fallopian tube0.63787
breast/ovarian cancer syndrome0.3882
Prevention Editorial Board0.384816
National Cancer Institute0.445029
primary peritoneal cancer0.60944
increased risk0.383316
cancer information summary0.437953
PDQ Ovarian0.447122
breast cancer prevention0.37908
ovarian cancer0.978586
cancer patients0.359808
Cancer Care page0.379399
slightly increased risk0.38086
Early ovarian cancer0.493894
cancer risk factor0.422611
PDQ summary0.375317
cancer risk assessment0.407064
NCI PDQ cancer0.412389
cancer clinical trials0.393106
risk factors0.470948
peritoneal cancer prevention0.426918
fallopian tubes0.510186
cancer information summaries0.390404
hormone replacement therapy0.391262
comprehensive cancer information0.390371
ovarian cancer prevention0.478328
risk0.594719
ovarian tissue0.417842
ovarian cancer syndrome0.488439
CLICK HERE
1459 National Cancer Institute Html en Genetics of Endocrine and Neuroendocrine Neoplasias (PDQ®)–Health Professional Version Endocrine and neuroendocrine neoplasias may be inherited in syndromes such as multiple endocrine neoplasia types 1 and 2 (MEN1 and MEN2), familial pheochromocytoma and paraganglioma, and Carney-Stratakis syndrome. Learn about the genetics, clinical manifestations, and management of these hereditary cancer syndromes in this expert-reviewed summary.
men1 gene0.496062
endocrine neoplasia syndrome0.465022
moderate-risk pathogenic variants0.451346
Zollinger-Ellison syndrome0.472267
gene pathogenic variant0.461604
familial multiple endocrine0.465896
MEN1 pathogenic variant.0.494678
M918T pathogenic variants0.452285
Ann Surg0.450141
Dutch MEN1 Study0.479758
gene pathogenic variants0.465665
pathogenic variant detection0.451143
pathogenic variant testing0.449159
Common pathogenic variants0.452259
C634R pathogenic variant0.448895
recent Dutch MEN10.461537
family members0.473057
MEN1 section0.451905
specific pathogenic variants0.452497
patients0.486964
ATA-H pathogenic variants0.452298
Preoperative multiple endocrine0.451658
certain endocrine tumors0.451569
Clin Endocrinol Metab0.506906
MEN1 multicenter study0.456509
pathogenic variant analysis0.462761
et al.0.511423
pancreaticoduodenal endocrine tumors0.47075
MEN1 diagnosis0.459578
MEN1 testing0.457802
MEN1 pathogenic variants0.509643
endocrine neoplasia type0.912503
PUBMED Abstract0.487944
multiple endocrine neoplasia0.985247
pathogenic variants0.602394
term pathogenic variant0.454804
MEN1 Study Group0.48033
pathogenic variant yield0.450166
primary hyperparathyroidism0.470964
RET pathogenic variant0.455734
pathogenic variant prevalence0.453316
RET pathogenic variants0.474875
pancreatic endocrine tumors0.459209
Abstract0.518889
C634Y pathogenic variant0.449059
calcitonin levels0.449053
term multiple endocrine0.45844
germline pathogenic variants0.463296
CLICK HERE
1658 National Cancer Institute Html en Childhood Central Nervous System Embryonal Tumors Treatment (PDQ®)–Patient Version Expert-reviewed information summary about the treatment of childhood medulloblastoma, nonmedulloblastoma embryonal tumors, and pineal tumors.
clinical trial0.453805
treatment0.609377
general information0.246182
childhood cns0.275323
nonmedulloblastoma embryonal tumors0.299989
cancer cells0.278431
embryonal tumors0.938688
brain0.391786
chemotherapy0.262908
CNS embryonal tumors0.85028
clinical trial search0.248648
cancer clinical trials0.254529
brain tumors0.23742
stem cell rescue0.406691
children0.244267
radiation therapy0.844353
clinical trials0.725208
cancer0.65116
standard treatment0.256014
information0.249598
spinal cord0.615415
CNS embryonal tumor0.222757
CLICK HERE
1993 National Cancer Institute Html es Tratamiento del craneofaringioma infantil (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento del craneofaringioma infantil
radiocirugía estereotáctica0.762185
siguientes procedimientos0.374594
cráneo.ampliar craneotomía0.361774
siguientes especialistas0.367839
radioterapia causa0.437652
vía oral0.344906
rayos x0.457932
PDQ Descripción0.478828
encéfalo benignos0.464072
rayos gamma0.344103
efectos tardíos0.944822
PDQ Efectos tardíos0.500304
National Cancer Institute0.34653
tumores benignos0.729016
siguientes riesgos0.333562
Instituto Nacional0.381114
PDQ Tratamiento0.757616
determinados cambios0.335985
nuevos tipos0.356873
Physician Data Query0.470403
sistema nervioso central0.413873
especial llamada acelerador0.379394
Aboutâ„¢ Brain Tumors0.36107
simple vista0.352074
siguientes enlaces0.33948
pequeño recipiente0.345075
siguientes pruebas0.387403
CLICK HERE
2028 National Cancer Institute Html es Exámenes de detección del cáncer colorrectal (PDQ®)–Versión para profesionales de salud Sumario de información revisada por expertos sobre las pruebas que se usan para detectar el cáncer colorrectal.
accessed july0.61974
materia fecal versus0.569405
Cancer Statistics Review0.717463
American Cancer Society0.622678
prueba gfobt hemoccult-ii0.559469
FOBT bienales0.553931
colon distal0.622974
Winawer SJ0.556908
colorectal cancer0.922778
tubo gi0.54546
ensayo danés0.593036
Estados Unidos0.603591
Cancer Incidence0.540817
IC 95 %)Riesgo0.584646
prueba fobt0.659659
Sin efecto0.549689
fecal occult blood0.562549
detección norccap0.581363
pruebas fobt0.558088
SEER Cancer Statistics0.726137
incidencia mortalidad0.623577
cancer screening0.585359
siguientes ciclos0.545695
prueba gFOBT0.591796
reino unido0.63003
detección diseño0.605975
CCR Validez0.68242
Dukes C0.550116
Cancer Facts0.543305
Dukes D0.548677
Colonoscopia Estudios0.59156
automatizados tipo fit0.569845
Colorectal Cancer Prevention0.562051
Noone AM0.6798
National Polyp Study0.591363
Países Bajos0.569859
vías respiratorias0.55455
National Cancer Institute0.711885
Rozen P0.556076
%)c incidencia0.544729
Levin B0.551596
exámenes bienales0.563089
Sin rehidratación0.656137
Krapcho M0.597589
colonoscopia versus0.571346
análisis fit0.820245
sigmoidoscopia detecta lesiones0.562884
Cancer Screening Trial0.547357
adenomas distales versus0.573736
CLICK HERE
4288 National Cancer Institute Html en Delirium and Cancer Treatment Delirium is a confused mental state. Symptoms may include changes in thinking and sleeping. In cancer patients, it may be caused by medicine, dehydration, or happen at the end of life. Delirium may be mistaken for depression or dementia.
familiar possessions0.460098
hyperactive delirium0.731474
questions0.420272
family member0.493907
health care team0.510247
brain tumors0.464705
poor nutrition0.45797
judgment0.429189
awareness0.413241
dehydration0.454891
health care providers0.496178
family members0.628462
high doses0.463949
risk factors0.511453
Control surroundings0.456835
patterns0.413223
list0.42027
bowels0.414692
symptoms0.455716
hypoactive delirium0.762002
careful observation0.458029
Early monitoring0.462105
decision-making0.411721
Mixed delirium0.689111
older age0.46515
dementia0.412808
conditions0.42534
mental state0.468032
different treatments0.463034
infection0.411593
supportive care approaches0.497253
sedation0.440043
life0.425096
causes0.425024
certain medicines0.522455
PDQ® summary0.45633
end0.425106
decisions0.423293
behavior0.413211
delirium0.955275
short period0.469724
main types0.467622
advanced cancer0.462991
patient changes0.458323
withdrawal0.412724
professional version0.456367
doctor0.420247
bladder0.411574
time0.413034
CLICK HERE
17281 National Cancer Institute Html es Superar sus sentimientos Las personas con cáncer avanzado tienen algunos sentimientos en común. Usted verá que no está solo cuando le toque enfrentar estos sentimientos.
largos ratos0.703581
CLICK HERE
17283 National Cancer Institute Html es Instrucciones por adelantado Información sobre las instrucciones por adelantado, los cuales son documentos legales que le permiten a usted decidir con anticipación como desea que le brinden atención médica.
organización nacional0.667013
aging with dignity0.502826
resumidas cuentas0.476767
American Bar Association0.490541
Cinco deseos0.457338
Five Wishes0.456319
Voicing My Choices0.497173
cuidados paliativos0.908507
Mucha gente0.472554
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.